Skip to main content

Research

The Department of Pathology is deeply invested in scientific efforts to improve treatments in our field. Learn more about our department’s investigations below.

Message from the Vice Chair

"We are driven by a shared passion for discovery and a deep commitment to advancing human health through innovative research programs and collaborative partnerships among scientists and pathologists."

Peng Ji, MD, PhD
Vice Chair of Research 

Read Full Message

Areas of Research

Members of the Department of Pathology are defining the cellular and molecular basis of disease toward the development of new and improved strategies to diagnose and treat, inherited, acquired and infectious disorders. Learn more about the work being done in our labs.

Research Areas

Affiliated Research Centers and Institutes

The faculty members of Northwestern University Feinberg School of Medicine’s Department of Pathology are engaged in research within the department and throughout Northwestern Medicine and Northwestern University. Our work throughout the community, including director appointments, illustrate the importance we put on scientific collaboration.

Research Cores

Core facilities provide cost-efficient access of state-of-the-art equipment, the most current technologies and expert technical advice to individual scientists.

Learn more about our affiliated cores

Research Resources

Recent Publications

Adaptation and changing phenotypes through transgenerational epigenetics.

Van Winkle LJ, Ryznar RJ, Iannaccone PM.

Epigenetics. 2025 Dec;20(1):2460246. doi: 10.1080/15592294.2025.2460246. Epub 2025 Aug 13.

Life-course socioeconomic position and the gut microbiome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Batalha MA, LeCroy MN, Lin J, Peters BA, Qi Q, Wang Z, Wang T, Gallo LC, Talavera GA, McClain AC, Thyagarajan B, Daviglus ML, Hou L, Llabre M, Cai J, Kaplan RC, Isasi CR.

Gut Microbes. 2025 Dec;17(1):2479772. doi: 10.1080/19490976.2025.2479772. Epub 2025 Mar 18.

Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML.

Lin AY, Rink JS, Yang E, Small S, Gerber JJ, Zak TJ, Altman J, Abaza Y, Platanias LC, Gordon LI, Thaxton CS.

Blood Neoplasia. 2025 Jun 3;2(4):100122. doi: 10.1016/j.bneo.2025.100122. eCollection 2025 Nov.

Risk assessment and underlying mechanisms of pydiflumetofen resistance in Alternaria tenuissima and Alternaria alternata.

Luo L, Shao G, Li X, Dai T, Miao J, Lu X, Peng Q, Liu X.

Pestic Biochem Physiol. 2025 Nov;214:106584. doi: 10.1016/j.pestbp.2025.106584. Epub 2025 Jul 19.

Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium.

Zaman F, Zhu X, Hunt JH, Rozek G, Eby Y, Hussain S, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock P, Gilbert A, Hand J, Morris MI, Stosor V, Mehta SA, Small CB, Schaenman J, Santos CAQ, Aslam S, Wojciechowski D, Malinis M, Haidar G, Odim J, Morsheimer M, Segev DL, Redd AD, Durand CM, Tobian AAR.

Clin Immunol. 2025 Nov;280:110563. doi: 10.1016/j.clim.2025.110563. Epub 2025 Jul 11.

Clinical features of retinal vasculitis: A systematic review and meta-analysis from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3.

Cifuentes-González C, Le Tong Y, Rojas-Carabali W, Mejía-Salgado G, Putera I, Song XYR, Walter CFY, Shengjuan Z, Chan R, Mobasserian A, Nora RD, Biswas J, Gangaputra S, Pulido JS, Kempen JH, Nguyen QD, de la Torre A, Gupta V, Rosenbaum JT, Agrawal R; REVISE-IUSG study group.

Surv Ophthalmol. 2025 Nov-Dec;70(6):1144-1159. doi: 10.1016/j.survophthal.2025.04.001. Epub 2025 May 2.

Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology.

Scariot DB, Staneviciute A, Machado RRB, Yuk SA, Liu YG, Sharma S, Almunif S, Arona Mbaye EH, Nakamura CV, Engman DM, Scott EA.

Biomaterials. 2025 Nov;322:123358. doi: 10.1016/j.biomaterials.2025.123358. Epub 2025 Apr 22.

Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer.

Stringer-Reasor EM, Saha P, Kocherginsky M, Lastra R, Baker G, Lenygel E, Karrison T, Olalde L, Mokrzycki E, Hahn OM, Hoffman PC, Conzen SD, Fleming GF, Nanda R.

Breast Cancer Res Treat. 2025 Oct;213(3):347-354. doi: 10.1007/s10549-025-07783-7. Epub 2025 Aug 8.

Unveiling the Molecular Landscape of MPO in Kikuchi's Disease: Protein Expression, mRNA Levels, and Genetic Polymorphisms.

Chang C, Zhang M, Chang Y, Ma Y, Li W.

Int J Lab Hematol. 2025 Oct;47(5):898-905. doi: 10.1111/ijlh.14509. Epub 2025 Jul 19.

Be a part of our future discoveries.Giving

Follow Pathology on FacebookInstagram